Showing Case Studies
First Look at Part B Discarded Drug Units for 2021
As guidance on the wastage provision in last year’s infrastructure package draws closer, expected in the annual rule-cycle, ADVI SAVEs analyzed Medicare Part B drug discarded unit trends and found a 132% increase in the number of drugs above the 10% threshold over the past 5 years. We take a closer look at which products, […]
Read more
Evaluation and Strategic Planning for Combination Pricing
Our work to evaluate potential strategies to implement Combination Pricing and understand impact to ASP.
Read more
Strategic Planning for Part B Launch
Our work to prepare manufacturer marketing and field teams for successful local Part B launch with Medicare Administrative Contractors (MACs).
Read more
Value/Price Message Development for Executive Team
Our work to better prepare executive team for drug pricing and value debate, assisting in training field-based personnel on customer reimbursement/pricing/value questions.
Read more